← All Companies
Scinai Immunotherapeutics Ltd.
SCNI · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 45 employees
Business Summary EX-10.10 6 f10k2022ex10-10_biondvax.htm EMPLOYMENT AGREEMENT DATED SEPTEMBER 5, 2018, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND ELAD MARK Exhibit 10.10
Latest Stock Quote
SCNI 2026-05-29
$0.45
O:$0.451 H:$0.4892 L:$0.45 Vol:0.5M VWAP:$0.4692
origin leaf: 8d1085011d21d51d5a2e66a93db4a6750056f368ca639cd93e8608dad3d6448f
Annual Reports (10-K) Filed Period Accession Source Full Text 2023-04-17 2022-12-31 0001213900-23-030228 EDGAR 78K words
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2023-05-15 2023-03-31 0001213900-23-039875 EDGAR 15K words
Recent Current Reports (8-K) Filed Accession Source Full Text 2023-06-08 0001213900-23-047493 EDGAR 1K words 2023-05-11 0001213900-23-038612 EDGAR — 2023-05-04 0001213900-23-036435 EDGAR — 2023-05-04 0001213900-23-036129 EDGAR —
293 total filings indexed. 287 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001611747
Ticker SCNI
Exchange Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Incorporated L3
Website https://www.scinai.com
Listed 2015-05-12
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 53de86d986017f2162c87845c27497652fb8ac55537deafe8cbad3540ac937d4
parent: 440286ab3169596a352a06a72667e63fce12db6d2ab667d0c14eb3c6ce4dcc1c
content hash: 03ecd4e2b4d70121285cfc29150d888dfb7a63e7b31ead198ec83a7f095e23d9
signed: 2026-06-02T19:02:34.043Z
sources: 3 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf